Jiangsu Hengrui Medicine
600276.SS
$6.08
Share price
5.28%
Change (1 day)
-13.27%
Change (1 year)
Categories
Jiangsu Hengrui Medicine Company Limited is a Chinese pharmaceutical company engaged in the R&D, manufacturing and sales of healthcare products, including antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents and antibiotics
Jiangsu Hengrui Medicine (600276.SS) - P/B ratio
P/B ratio as of April 2024 : 6.91
According to Jiangsu Hengrui Medicine
's latest financial reports the company has a price-to-book ratio of 6.91.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Jiangsu Hengrui Medicine - P/B ratio (from 2001 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 7.24 | 14.47% |
| 2022-12-31 | 6.33 | -30.61% |
| 2021-12-31 | 9.12 | -52.76% |
| 2020-12-31 | 19.3 | 24.36% |
| 2019-12-31 | 15.5 | 59.24% |
| 2018-12-31 | 9.75 | -19.7% |
| 2017-12-31 | 12.1 | 46.35% |
| 2016-12-31 | 8.29 | -10.6% |
| 2015-12-31 | 9.28 | 34.21% |
| 2014-12-31 | 6.91 | -10.93% |
| 2013-12-31 | 7.76 | 13.49% |
| 2012-12-31 | 6.84 | -9.17% |
| 2011-12-31 | 7.53 | -41.38% |
| 2010-12-31 | 12.8 | 5.05% |
| 2009-12-31 | 12.2 | 24.27% |
| 2008-12-31 | 9.84 | -33.32% |
| 2007-12-31 | 14.8 | 74.66% |
| 2006-12-31 | 8.45 | 148.87% |
| 2005-12-31 | 3.40 | 6.54% |
| 2004-12-31 | 3.19 | 34.53% |
| 2003-12-31 | 2.37 | -25.07% |
| 2002-12-31 | 3.16 |